Nusano News

Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement

The following is a copy of a press release issued by Cellectar BiosciencesPartnership Provides Long-Term Supply of Iodine-125 and Actinium-225 Supports Advancement of...

dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply

Jun 19, 2025

Alpha-emitting radioisotope expected to play an essential role in next-generation targeted cancer therapies DURHAM, N.C. and WEST VALLEY CITY, Utah – June 19, 2025 – dGenThera, Inc., a biotechnology company pioneering theranostic molecular pairs, and Nusano, a...

Ratio Therapeutics and Nusano Enter Long-Term, Multi-Isotope Supply Agreement to Boost Production of Cancer Radiopharmaceuticals

Jun 17, 2025

Agreement provides Ratio access to Nusano-produced radioisotopes for oncology diagnostics and therapeutics Accelerates Ratio’s clinical pipeline with copper-64 for PET imaging and lutetium-177 and actinium-225 for targeted therapy Bolsters both companies’...

Nusano Announces Breakthrough HALEU Program Expected to Produce Up to 350 Metric Tons of Fuel Annually for Advanced Nuclear Reactors

Jun 11, 2025

Reservations available now, commercial production deliveries begin Q1 2027 Proprietary process with reduced environmental impacts Efficient domestic supply chain needed to support projected growth in energy demand from increased electrification and energy-intensive...

Nusano Stable Isotope Program Enriches Gadolinium-160 to 99.2% Purity

Jun 10, 2025

Domestic stable isotope program key to stabilizing supply chains, enabling innovation WEST VALLEY CITY, Utah – June 10, 2025 – Nusano today announced it has successfully enriched gadolinium-160 (Gd-160) to 99.2% purity, a significant milestone demonstrating the...

Registration for 2025 World Astatine Community Meeting Now Open

May 12, 2025

Radiopharmaceutical experts and researchers to gather June 19-20 in New OrleansNEW ORLEANS – May 12, 2025 – The first-ever U.S.-based meeting of the World Astatine Community will take place June 19-20, 2025 at the Sheraton in downtown New Orleans. The event will...

Nusano to Participate in Radiopharma Supply Chain Panel at the 21st Annual PEGS Summit Boston

May 12, 2025

WEST VALLEY CITY, Utah – May 12, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced its Chief Product Officer, Kevin Haehl, will participate in a radioisotope supply chain panel discussion at the 21st Annual PEGS (Protein...

Nusano Names Rachel Culbertson VP of Supply Chain

Apr 30, 2025

WEST VALLEY CITY, Utah – April 30, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced the appointment of Rachel Culbertson as Vice President of Supply Chain. Culbertson’s leadership will be instrumental as Nusano scales to...

Clarity signs high-volume commercial-scale copper-64 Supply Agreement with Nusano

Apr 17, 2025

The following is a copy of a press release issued by Clarity Pharmaceuticals on April 17, 2025 in Australia. Minor edits have been made in this copy to account for English spelling preferences in the United States.Highlights Clarity has signed a commercial-scale...

Nusano’s Jzaneen Lalani Named to Top 50 Women Leaders in Healthcare Technology List

Mar 7, 2025

WEST VALLEY CITY, Utah – March 7, 2025 – The Healthcare Technology Report has named Jzaneen Lalani to its Top 50 Women Leaders in Healthcare Technology of 2024 list. Lalani is the Chief Business Officer (CBO) of Nusano, a physics company working to bring supply...

Nusano to Present at B. Riley Precision Oncology & Radiopharma Conference

Feb 25, 2025

WEST VALLEY CITY, Utah – Feb. 25, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced company management will present at the B. Riley Precision Oncology & Radiopharma Conference on Friday, Feb. 28, 2025 in New York City....

« Older Entries

BLOG Posts

Nusano CEO Chris Lowe on Connor Group Podcast